Articles

As biopharmaceutical companies focus tirelessly on developing a vaccine for the COVID-19 virus, they are expected to both rapidly develop vaccines and then scale up into mass production. In order to achieve to these goals, they must have access...

Treatments for diseases of all types are important. Treatments for a disease that is central to a global pandemic are beyond important. We are finally seeing major progress for vaccines to prevent the spread of COVID-19 ( https://www.worldpharmatoday.com/news/pfizer-and-biontech-aim-to-start-testing-coronavirus-vaccines-in-humans-by-late-april/ )....

The COVID-19 pandemic has exposed some significant frailties in the physical clinical supply chain. As governments, medical professionals and life science organisations around the world direct their energy and resources to curtailing the pandemic, a challenge that requires attention,...

Introduction: Self-administration of drugs is on the rise – due to a drastic surge in lifestyle-related diseases, as well as major advances in oncology and hormone therapy. Thanks to the use of auto-injectors, today patients can be treated, or...

Introduction: As the complexity of pharmaceutical research and development increases constantly, its innovation productivity defined as the successful approval and launch of truly novel drugs and therapies, has declined since years. To boost its innovation productivity,the pharma industry has...

Introduction: Quality control laboratories play a vital role in pharmaceutical manufacturing, from the evaluation of raw materials through to the release of the final packaged product. They are pivotal in ensuring the safety and efficacy of products administered to...

Introduction: Russia began transforming its pharma supply chain on December 29, 2017, when President Vladimir Putin signed Federal LawNo.425-FZ. This legislation aims to streamline the quality control of pharmaceuticals, protect against counterfeit medicines, and monitor supply, demand, and expenditure. Phased implementation...